While the norm is to view an audit as a stressful, time-consuming experience, audits can paint a picture not visible to the naked eye and are a valuable exercise to gauge the current health of a pharmaceutical patient support program.
Archbow's experience with program migrations has taught us what to anticipate, how to formulate realistic expectations, and where to find the right fit for teams needing a change. Q&A with Anna Beth Lindenmeyer
Poor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking competitive therapeutic options. For some pharma companies that equates to as much as $22,500 in lost profit DAILY.